Drug firms call on FDA to add to guidance on trial enrichment

03/25/2013 | OutSourcing-Pharma.com

Large drug firms including Merck & Co., Eli Lilly and Co. and Pfizer urged the FDA to bolster its draft guidance on enrichment measures for clinical trials with additional examples involving various therapeutic areas. Pharmaceutical companies also called for increased guidance involving diagnostics.

View Full Article in:

OutSourcing-Pharma.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD